Comments on the FDA’s Draft Guidances on the Prescription Requirement Under Section 503A and the Facilities Definition Under Section 503B July 18, 2016
Letter to U.S. Congress Conference Committee for the Comprehensive Addiction and Recovery Act July 1, 2016
Comments on the FDA’s Draft Interim Policy on Compounding Drugs Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act December 22, 2015
Public Citizen | Publications – Testimony of Peter Lurie, M.D., M.P.H and Hillary Peabody, M.P.H before the FDA Transparency Task Force (HRG Publication #1883)
Public Citizen | Publications – Testimony of Sidney M. Wolfe, MD, Before the House Subcommittee on Health and the Environment Hearings on H.R.S 3199-3201. (HRG Publication #1391)
Public Citizen Urges the FDA to Retract Industry-Centered “Patient Preference” Guidance August 17, 2015